GSA Capital Partners »

Perspective Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $237k 86k 2.75

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Perspective Therapeutics

FMR
BlackRock
Vanguard Group
Avidity Partners Management
Millennium Management
Nicholson Wealth Management Group
Geode Capital Management
Nuveen
Opaleye Management
State Street Corporation
Patient Square Capital
Hills Bank And Trust Company
UBS Group
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Perspective Therapeutics